InterCure Ltd (INCR) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.00 is considered Undervalued compared with the five-year average of -0.39. The fair price of InterCure Ltd (INCR) is between +Inf to +Inf according to relative valuation method. Compared to the current price of 0.83 USD , InterCure Ltd By Undervalued By Fair.

Relative Value

Fair Zone

+Inf-+Inf

Current Price：0.83

Fair

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is InterCure Ltd (INCR) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

InterCure Ltd (INCR) has a current Price-to-Book (P/B) ratio of 0.43. Compared to its 3-year average P/B ratio of 0.66, the current P/B ratio is approximately -34.22% higher. Relative to its 5-year average P/B ratio of 1.26, the current P/B ratio is about -65.68% higher. InterCure Ltd (INCR) has a Forward Free Cash Flow (FCF) yield of approximately -10.39%. Compared to its 3-year average FCF yield of -6.95%, the current FCF yield is approximately 49.42% lower. Relative to its 5-year average FCF yield of -3.66%, the current FCF yield is about 183.74% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for INCR competitors is 2.65, providing a benchmark for relative valuation. InterCure Ltd Corp (INCR.O) exhibits a P/S ratio of 0.00, which is -100% above the industry average. Given its robust revenue growth of 7.52%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of INCR increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of INCR in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is INCR currently overvalued or undervalued?

What is InterCure Ltd (INCR) fair value?

INCR's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of InterCure Ltd (INCR) is between +Inf to +Inf according to relative valuation method.

How does INCR's valuation metrics compare to the industry average?

The average P/S ratio for INCR's competitors is 2.65, providing a benchmark for relative valuation. InterCure Ltd Corp (INCR) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of 7.52%, this premium appears unsustainable.

What is the current P/B ratio for InterCure Ltd (INCR) as of Mar 04 2026?

As of Mar 04 2026, InterCure Ltd (INCR) has a P/B ratio of 0.43. This indicates that the market values INCR at 0.43 times its book value.

What is the current FCF Yield for InterCure Ltd (INCR) as of Mar 04 2026?

As of Mar 04 2026, InterCure Ltd (INCR) has a FCF Yield of -10.39%. This means that for every dollar of InterCure Ltd's market capitalization, the company generates -10.39 cents in free cash flow.

What is the current Forward P/E ratio for InterCure Ltd (INCR) as of Mar 04 2026?

As of Mar 04 2026, InterCure Ltd (INCR) has a Forward P/E ratio of 0.00. This means the market is willing to pay $0.00 for every dollar of InterCure Ltd's expected earnings over the next 12 months.

What is the current Forward P/S ratio for InterCure Ltd (INCR) as of Mar 04 2026?

As of Mar 04 2026, InterCure Ltd (INCR) has a Forward P/S ratio of 0.00. This means the market is valuing INCR at $0.00 for every dollar of expected revenue over the next 12 months.

INCR Valuation